The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
4 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $7,439,250 in first-year total cost, median $1,523,043.
Most frequent study sections
- Special Emphasis Panel[ZRG1 ETTN-H (11)]2
- Special Emphasis Panel[ZRG1 ETTN-A (11)]1
- Special Emphasis Panel[ZRG1 ETTN-C (10)]1
Most frequent institutions
- AFASCI, INC.1
- DIAGNOSTIC CONSULTING NETWORK, INC.1
- INHIBIKASE THERAPEUTICS1
- PHOENIX NEST, INC.1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2019 | Advanced therapeutic for Parkinson's Disease2R44NS103695-03 | WERNER, MILTON H. | INHIBIKASE THERAPEUTICS, GA | $1,554,108 | ZRG1 |
| 2019 | Development of a Field-Deployable Device to Rapidly Measure Blood Cyanide Levels2R44NS076359-04A1 | BOEHRINGER, HANS | DIAGNOSTIC CONSULTING NETWORK, INC., CA | $1,216,759 | ZRG1 |
| 2018 | Development and validation of therapy for mucopolysaccharidosis III2U44NS089061-04 | CHOU, TSUI-FENDICKSON, PATRICIA IGLASS, CHARLES ALEXANDERWOOD, JILL | PHOENIX NEST, INC., NY | $3,176,406 | ZRG1 |
| 2018 | IND-enabling studies on novel Cav3 T-channel modulators for treatment of neuropathic pain2R44NS086343-04 | XIE, XINMIN SIMON | AFASCI, INC., CA | $1,491,977 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.